Convergent Evolution: Shaping the import system of mitochondria
Mitochondria are organelles that fulfil a variety of critical functions in eukaryotic cells, and the event that resulted in their creation two billion years ago – when a bacterium fused with an ancient cell – was a defining moment in the evolution of life (Gray et al., 1999). However, the mitochondrial genome encodes a mere 13 different polypeptides, so the vast majority of the roughly 1500 mitochondrial proteins are made in the cytosol, and then imported into the organelle. These proteins are recognized and processed by various complexes which are embedded in the two membranes (the inner and outer mitochondrial membrane) that enclose a mitochondrion (Schmidt et al., 2010; Dolezal et al., 2006).
The import proteins present in the mitochondrial membranes can fold to form one of two structures: an α-helix or a β-barrel. How β-barrel proteins are taken into the mitochondrial outer membrane in the first place has been studied in much detail, and this process requires the translocase complex of the outer membrane, or TOM, to work with a structure called SAM (sorting and assembly machinery). The TOM complex is thought to be the main entrance for all mitochondrial proteins, irrespective of their final location within the organelle.
By contrast, it is less clear how α-helix proteins are brought to the outer membrane of mitochondria. However, several studies have suggested that, in fungi, a third ‘MIM’ (for mitochondrial import machinery) complex is involved (Figure 1; Becker et al., 2008). So far, it is known that Mim1 and Mim2 – the two proteins that form the MIM complex – are present in fungi but not in other eukaryotes.
Biochemical and genome analyses of the TOM and SAM complexes across different organisms show that only a few subunits (Tom22, Tom40 and Sam50) are conserved in all eukaryotes. It is likely that the protein import system in the bacteria that became the modern mitochondria was made from these subunits. Other subunits are not conserved: for example, sequence analyses of two subunits of the TOM complex, Tom20 and Tom70, indicated that they evolved separately in fungi and plants. However, structural experiments showed that these subunits have adopted common structures that allow them to recognize and import mitochondrial proteins (Perry et al., 2006).
This was the first time a process known as convergent evolution – when species that are not related independently evolve similar structures to perform identical roles – had been observed in the mitochondrial import system. Further studies revealed that the trypanosome T. brucei also has receptors that have evolved separately from those in fungi and animals, but then converged to perform the same role (Mani et al., 2015). Now, in eLife, Doron Rapaport of the University of Tübingen, André Schneider of the University of Bern, and colleagues – Daniela Vitali, Sandro Käser and Antonia Kolb (as joint first authors), and Kai Dimmer – report another exciting example of convergent evolution, this time not for accessory receptor subunits but for a core import complex (Vitali et al., 2018).
In T. brucei, a protein called pATOM36 is found in the outer membrane of the mitochondria, where it helps to import other proteins. It is not related to the Mim1 receptor found in fungi, and their sequences are very dissimilar, but Vitali et al. have found that fungi in which the MIM complex has been replaced with pATOM36 can still import proteins. However, pATOM36 is not as effective as Mim1, possibly because it has evolved to prefer substrates that are only found in trypanosomes.
Likewise, Vitali et al. show that the MIM complex can take the place of pATOM36 in trypanosomes, providing that Mim1 and Mim2 are expressed at approximately the same levels. These largely unexpected results suggest that the MIM complex and pATOM36 perform their roles alone; indeed, it is unlikely that they could have found molecular partners to work with when placed in an unfamiliar environment.
How can MIM and pATOM36 replace each other when they are so distantly related? Both are embedded in the outer mitochondrial membrane, and are formed of several subunits, but the exact topology of pATOM36 is unknown. Structural analyses may provide important clues because a similarity in their structure could explain the overlap in their function. This would not be unprecedented; for example, proteins found in yeast mitochondria and bacteria fold into similar structures that allow them to bind to the same types of molecules (Alcock et al., 2008).
Another possibility is that MIM and pATOM36 have distinct structures that work in different ways but reach the same outcome – and attach to the same proteins. Again this would not be unprecedented; enzymes present in yeast and bacteria can use distinct mechanisms to create identical chemical links known as disulfide bonds in proteins (Riemer et al., 2009).
The work of Vitali et al. provides an intriguing hint that convergent evolution may have added components to the ancestral core import machinery in a modular way. In the future, biochemical, structural and genomics analyses of distant species could be combined to provide interesting clues, and maybe some surprises, about the evolution of the protein import systems of mitochondria. These answers may help us understand how an ancestral bacterium morphed into the organelle that powers most eukaryotic species today.
Biogenesis of the mitochondrial TOM complex: Mim1 promotes insertion and assembly of signal-anchored receptorsThe Journal of Biological Chemistry 283:120–127.https://doi.org/10.1074/jbc.M706997200
Mitochondrial evolutionScience 283:1476–1481.https://doi.org/10.1126/science.283.5407.1476
Mitochondrial protein import: from proteomics to functional mechanismsNature Reviews Molecular Cell Biology 11:655–667.https://doi.org/10.1038/nrm2959
Article and author information
- Version of Record published: June 20, 2018 (version 1)
© 2018, Tokatlidis
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
- Page views
Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
- Biochemistry and Chemical Biology
- Microbiology and Infectious Disease
Darunavir (DRV) is exceptional among potent HIV-1 protease inhibitors (PIs) in high drug concentrations that are achieved in vivo. Little is known about the de novo resistance pathway for DRV. We selected for resistance to high drug concentrations against 10 PIs and their structural precursor DRV. Mutations accumulated through two pathways (anchored by protease mutations I50V or I84V). Small changes in the inhibitor P1'-equivalent position led to preferential use of one pathway over the other. Changes in the inhibitor P2'-equivalent position determined differences in potency that were retained in the resistant viruses and that impacted the selected mutations. Viral variants from the two pathways showed differential selection of compensatory mutations in Gag cleavage sites. These results reveal the high level of selective pressure that is attainable with fifth-generation PIs and how features of the inhibitor affect both the resistance pathway and the residual potency in the face of resistance.
- Biochemistry and Chemical Biology
Tyrosine kinases and SH2 (phosphotyrosine recognition) domains have binding specificities that depend on the amino acid sequence surrounding the target (phospho)tyrosine residue. Although the preferred recognition motifs of many kinases and SH2 domains are known, we lack a quantitative description of sequence specificity that could guide predictions about signaling pathways or be used to design sequences for biomedical applications. Here, we present a platform that combines genetically encoded peptide libraries and deep sequencing to profile sequence recognition by tyrosine kinases and SH2 domains. We screened several tyrosine kinases against a million-peptide random library and used the resulting profiles to design high-activity sequences. We also screened several kinases against a library containing thousands of human proteome-derived peptides and their naturally-occurring variants. These screens recapitulated independently measured phosphorylation rates and revealed hundreds of phosphosite-proximal mutations that impact phosphosite recognition by tyrosine kinases. We extended this platform to the analysis of SH2 domains and showed that screens could predict relative binding affinities. Finally, we expanded our method to assess the impact of non-canonical and post-translationally modified amino acids on sequence recognition. This specificity profiling platform will shed new light on phosphotyrosine signaling and could readily be adapted to other protein modification/recognition domains.